Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1071-1080 of 2932 for cancer

Edit search filters
  1. A Study To Evaluate MUC1 Vaccine To Prevent Lung Cancer In Current And Former Smokers At High Risk For Lung Cancer

    Rochester, MN

  2. MUC1 Gene Expression

    Rochester, MN

  3. A Study Screening Mammograms for Women in Their 40s: Mammography Choice

    Rochester, MN

  4. Nemvaleukin Alfa (ALKS 4230) Monotherapy In Patients With Advanced Cutaneous Melanoma Or Advanced Mucosal Melanoma

    Jacksonville, FL, Rochester, MN

  5. GB5121 In Adult Subjects With Relapsed/Refractory CNS Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  7. Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes

    Rochester, MN

  8. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

    Rochester, MN

  9. A Study To Evaluate Larotrectinib To Treat Patients With Previously Untreated TRK Fusion Solid Tumors And TRK Fusion Relapsed Acute Leukemia

    Rochester, MN

  10. HEADLIGHT: Hypofractionated Proton Therapy For Head And Neck Cancers

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

.

Mayo Clinic Footer